What to do when you discover testicular cancer

Helping patients overcome fear and choose treatment

Guru Sonpavde, Lawrence Einhorn

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Testicular germ cell tumor is a paradigm for curable cancer. Early recognition and prompt institution of therapy, with referral to a specialized cancer center as needed, enable a favorable outcome in the vast majority of patients. Accurate serum tumor markers assist in diagnosis and are useful in following a patient's response to therapy. An important distinction in treatment as well as in prognosis is whether the tumor is nonseminomatous or seminomatous. The International Germ Cell Cancer Collaborative Group developed a patient-risk classification for the two types of tumor that is based on prognostic factors (ie, pretreatment tumor-markers levels, site of primary tumor, and presence of nonpulmonary visceral metastatis). Treatment is determined according to this risk classification and the stage of disease. Tumor confined to the testis may be curable with orchiectomy alone, whereas disease involving other sites often requires chemotherapy. Even in metastatic and recurrent disease the cure rate is high.

Original languageEnglish
Pages (from-to)229-236
Number of pages8
JournalPostgraduate Medicine
Volume105
Issue number4
StatePublished - 1999
Externally publishedYes

Fingerprint

Testicular Neoplasms
Fear
Neoplasms
Tumor Biomarkers
Therapeutics
Orchiectomy
Germ Cell and Embryonal Neoplasms
Testis
Referral and Consultation
Biomarkers
Drug Therapy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

What to do when you discover testicular cancer : Helping patients overcome fear and choose treatment. / Sonpavde, Guru; Einhorn, Lawrence.

In: Postgraduate Medicine, Vol. 105, No. 4, 1999, p. 229-236.

Research output: Contribution to journalArticle

@article{a784552ab5504bbc8d770804dffd6c7e,
title = "What to do when you discover testicular cancer: Helping patients overcome fear and choose treatment",
abstract = "Testicular germ cell tumor is a paradigm for curable cancer. Early recognition and prompt institution of therapy, with referral to a specialized cancer center as needed, enable a favorable outcome in the vast majority of patients. Accurate serum tumor markers assist in diagnosis and are useful in following a patient's response to therapy. An important distinction in treatment as well as in prognosis is whether the tumor is nonseminomatous or seminomatous. The International Germ Cell Cancer Collaborative Group developed a patient-risk classification for the two types of tumor that is based on prognostic factors (ie, pretreatment tumor-markers levels, site of primary tumor, and presence of nonpulmonary visceral metastatis). Treatment is determined according to this risk classification and the stage of disease. Tumor confined to the testis may be curable with orchiectomy alone, whereas disease involving other sites often requires chemotherapy. Even in metastatic and recurrent disease the cure rate is high.",
author = "Guru Sonpavde and Lawrence Einhorn",
year = "1999",
language = "English",
volume = "105",
pages = "229--236",
journal = "Postgraduate Medicine",
issn = "0032-5481",
publisher = "Medquest Communications LLC",
number = "4",

}

TY - JOUR

T1 - What to do when you discover testicular cancer

T2 - Helping patients overcome fear and choose treatment

AU - Sonpavde, Guru

AU - Einhorn, Lawrence

PY - 1999

Y1 - 1999

N2 - Testicular germ cell tumor is a paradigm for curable cancer. Early recognition and prompt institution of therapy, with referral to a specialized cancer center as needed, enable a favorable outcome in the vast majority of patients. Accurate serum tumor markers assist in diagnosis and are useful in following a patient's response to therapy. An important distinction in treatment as well as in prognosis is whether the tumor is nonseminomatous or seminomatous. The International Germ Cell Cancer Collaborative Group developed a patient-risk classification for the two types of tumor that is based on prognostic factors (ie, pretreatment tumor-markers levels, site of primary tumor, and presence of nonpulmonary visceral metastatis). Treatment is determined according to this risk classification and the stage of disease. Tumor confined to the testis may be curable with orchiectomy alone, whereas disease involving other sites often requires chemotherapy. Even in metastatic and recurrent disease the cure rate is high.

AB - Testicular germ cell tumor is a paradigm for curable cancer. Early recognition and prompt institution of therapy, with referral to a specialized cancer center as needed, enable a favorable outcome in the vast majority of patients. Accurate serum tumor markers assist in diagnosis and are useful in following a patient's response to therapy. An important distinction in treatment as well as in prognosis is whether the tumor is nonseminomatous or seminomatous. The International Germ Cell Cancer Collaborative Group developed a patient-risk classification for the two types of tumor that is based on prognostic factors (ie, pretreatment tumor-markers levels, site of primary tumor, and presence of nonpulmonary visceral metastatis). Treatment is determined according to this risk classification and the stage of disease. Tumor confined to the testis may be curable with orchiectomy alone, whereas disease involving other sites often requires chemotherapy. Even in metastatic and recurrent disease the cure rate is high.

UR - http://www.scopus.com/inward/record.url?scp=0033006059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033006059&partnerID=8YFLogxK

M3 - Article

VL - 105

SP - 229

EP - 236

JO - Postgraduate Medicine

JF - Postgraduate Medicine

SN - 0032-5481

IS - 4

ER -